Clinical Trial Update: Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations [NA]

View source ↗

Summary

Clinical study comparing HEMOBLAST Bellows to FLOSEAL Hemostatic Matrix in cardiothoracic operations has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiothoracic Surgery

Drugs mentioned

• FLOSEAL Hemostatic Matrix (Hemostatic matrix)
• HEMOBLAST Bellows (Hemostatic agent)

Snippet

Sponsor: Biom'Up France SAS | Conditions: Cardiothoracic Surgery | NA | Status: COMPLETED | Results posted: 2020-01-13